APA (7th ed.) Citation

Hisham Qosa, Claudia H. M. C. deOliveira, Giovanni Cizza, Eric J. Lawitz, Nicholas Colletti, Jeffrey Wetherington, . . . Giridhar S. Tirucherai. (2023). Pharmacokinetics, safety, and tolerability of BMS‐986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairment. Wiley.

Chicago Style (17th ed.) Citation

Hisham Qosa, Claudia H. M. C. deOliveira, Giovanni Cizza, Eric J. Lawitz, Nicholas Colletti, Jeffrey Wetherington, Edgar D. Charles, and Giridhar S. Tirucherai. Pharmacokinetics, Safety, and Tolerability of BMS‐986263, a Lipid Nanoparticle Containing HSP47 SiRNA, in Participants with Hepatic Impairment. Wiley, 2023.

MLA (9th ed.) Citation

Hisham Qosa, et al. Pharmacokinetics, Safety, and Tolerability of BMS‐986263, a Lipid Nanoparticle Containing HSP47 SiRNA, in Participants with Hepatic Impairment. Wiley, 2023.